Molecular mechanisms of tumor angiogenesis and tumor progression

被引:105
作者
Cavallaro, U [1 ]
Christofori, G [1 ]
机构
[1] Res Inst Mol Pathol, A-1030 Vienna, Austria
关键词
angiogenesis; metastasis; oncogenes; tumorigenesis; tumor suppressor genes;
D O I
10.1023/A:1006414621286
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The formation of new blood vessels (angiogenesis) is crucial for the growth and persistence of primary solid tumors and their metastases. Furthermore, angiogenesis is also required for metastatic dissemination, since an increase in vascular density will allow easier access of tumor cells to the circulation. Induction of angiogenesis precedes the formation of malignant tumors, and increased vascularization seems to correlate with the invasive properties of tumors and thus with the malignant tumor phenotype. In the last few years, the discovery and characterization of tumor-derived angiogenesis modulators greatly contributed to our understanding of how tumors regulate angiogenesis. However, although angiogenesis appears to be a rate-limiting event in tumor growth and metastatic dissemination, a direct connection between the induction of angiogenesis and the progression to tumor malignancy is less well understood. In this review, we discuss the most recent observations concerning the modulation of angiogenesis and their implications in tumor progression, as well as their potential impact on cancer therapy.
引用
收藏
页码:63 / 70
页数:8
相关论文
共 80 条
  • [1] AnandApte B, 1997, INVEST OPHTH VIS SCI, V38, P817
  • [2] HUMAN INTERFERON-INDUCIBLE PROTEIN-10 IS A POTENT INHIBITOR OF ANGIOGENESIS IN-VIVO
    ANGIOLILLO, AL
    SGADARI, C
    TAUB, DD
    LIAO, F
    FARBER, JM
    MAHESHWARI, S
    KLEINMAN, HK
    REAMAN, GH
    TOSATO, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (01) : 155 - 162
  • [3] Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways
    Arbiser, JL
    Moses, MA
    Fernandez, CA
    Ghiso, N
    Cao, YH
    Klauber, N
    Frank, D
    Brownlee, M
    Flynn, E
    Parangi, S
    Byers, HR
    Folkman, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (03) : 861 - 866
  • [4] Bergers G, 1998, INT J DEV BIOL, V42, P995
  • [5] Effects of angiogenesis inhibitors on multistage carcinogenesis in mice
    Bergers, G
    Javaherian, K
    Lo, KM
    Folkman, J
    Hanahan, D
    [J]. SCIENCE, 1999, 284 (5415) : 808 - 812
  • [6] Zinc-binding of endostatin is essential for its antiangiogenic activity
    Boehm, T
    O'Reilly, MS
    Keough, K
    Shiloach, J
    Shapiro, R
    Folkman, J
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 252 (01) : 190 - 194
  • [7] Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
    Boehm, T
    Folkman, J
    Browder, T
    OReilly, MS
    [J]. NATURE, 1997, 390 (6658) : 404 - 407
  • [8] How tumors become angiogenic
    Bouck, N
    Stellmach, V
    Hsu, SC
    [J]. ADVANCES IN CANCER RESEARCH, VOL 69, 1996, 69 : 135 - 174
  • [9] Cao Y, 1998, Prog Mol Subcell Biol, V20, P161
  • [10] GRO-BETA, GRO-ALPHA -C-X-C- CHEMOKINE, IS AN ANGIOGENESIS INHIBITOR THAT SUPPRESSES THE GROWTH OF LEWIS-LUNG-CARCINOMA IN MICE
    CAO, YH
    CHEN, C
    WEATHERBEE, JA
    TSANG, M
    FOLKMAN, J
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (06) : 2069 - 2077